Stallergenes SAS (GENP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Stallergenes SAS (GENP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Stallergenes SAS (GENP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Stallergenes SAS (GENP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
25 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Stallergenes SAS (Stallergenes), a subsidiary of Stallergenes Greer is a biopharmaceutical company, which provides treatments for allergy-related respiratory diseases. Stallergenes is headquartered in Antony, France.

Stallergenes SAS (GENP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key c

  
Source:
Document ID
GDPH81765D
Country
Industry
Ticker
GENP=FR
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Stallergenes SAS, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Stallergenes SAS, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Stallergenes SAS, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Stallergenes SAS, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Stallergenes SAS, Medical Devices Deals, 2010 to YTD 201691
Stallergenes SAS, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Stallergenes SAS, Pharmaceuticals &Healthcare, Deal Details1113
  Private Equity111
    Ares Life Sciences Acquires An Additional 27.32% Stake In Stallergenes112
  Partnerships131
    Stallergenes Exercises Option for Co-Development Agreement with ActoGeniX131
    Stallergenes Enters Into Co-Development Agreement With ActoGeniX141
    Stallergenes Enters In To Distribution Agreement With Greer Labs For Oralair151
    DBV Technologies Exercises Option for R&D Agreement with Stallergenes for Birch Allergy Treatment161
    DBV Technologies Enters Into Research Agreement With Stallergenes171
  Licensing Agreements181
    Stallergenes Enters into Licensing Agreement with Shionogi182
  Acquisition201
    Stallergenes Acquires Alergo Pharma, Allergen Immunotherapy Company201
    Stallergenes Acquires 2% Stake in DBV Technologies211
    Stallergenes Acquires Its UK-Based Distributor Medelo221
    Stallergenes To Acquire Pharma Company231
Locations And Subsidiaries241
  Head Office241
  Other Locations &Subsidiaries241
Appendix251
  Methodology251
  About GlobalData251
  Contact Us251
  Disclaimer251

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Stallergenes SAS (GENP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Stallergenes-SAS-GENP-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17208>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Stallergenes SAS (GENP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Stallergenes-SAS-GENP-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17208>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research